The plaque psoriasis drug Humira has been linked to drug-induced lupus erythematosus (DILE) in a case study published in the Journal of Clinical Pharmacy and Therapeutics. Humira, known chemically as adalimumab, is an immunosuppressant drug that is approved by the Food and Drug Administration (FDA) to treat arthritis, plaque psoriasis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis. The case study, detailed by Iva Lomicová, M.D., from Charles University in Pilsen, Czech Republic, and colleagues, involves a patient with severe psoriasis who was treated with adalimumab, but discontinued the medication two weeks prior to having a hysterectomy. A month later, she ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.